Today: 21 May 2026
Nebius (NBIS) stock rebounds after a wild session as Feb. 12 results loom
2 February 2026
1 min read

Nebius (NBIS) stock rebounds after a wild session as Feb. 12 results loom

New York, Feb 2, 2026, 16:04 EST — After-hours

  • Nebius shares ended up roughly 3.8%, bouncing back after a $6-plus swing during the session
  • The company will release its fourth-quarter and full-year 2025 results on Feb. 12, ahead of the market open
  • Traders await new clues on capacity expansion, spending, and funding

Nebius Group N.V. shares climbed Monday, finishing near $88.39, up roughly 3.8% after swinging between $82.41 and $89.21 during the session. Trading volume exceeded 9 million shares.

All eyes now turn to Feb. 12, when the Nasdaq-listed AI cloud company will release its Q4 and full-year 2025 earnings ahead of the market open, followed by a conference call at 8 a.m. Eastern.

This matters now because investors have been viewing Nebius as a high-beta indicator for demand in rented computing power used to train and operate AI models. The upcoming report is the closest thing on the calendar to a real check on how quickly customers are scaling up — and just how much cash the expansion is burning through.

The stock remains vulnerable to steep pullbacks. Despite Monday’s rebound, Nebius still trades far below its 52-week peak of $141.10.

Nebius provides access to GPU-intensive infrastructure and related services, a crowded space where smaller players vie with major cloud providers. Investors are closely watching if new capacity can be added quickly enough to keep up with demand without needing frequent capital raises.

In November, Reuters revealed that Nebius inked a five-year, $3 billion deal with Meta to provide AI infrastructure. This came after a separate Microsoft agreement that could total $17.4 billion by 2031, depending on GPU cluster deployment and availability. The report also highlighted Nebius’s revenue more than quadrupling in Q3 2025, alongside a wider loss driven by a surge in capital expenditures.

Funding is still an open issue. A prospectus supplement dated Nov. 12, 2025, reveals Nebius has launched an “at-the-market” offering for up to 25 million Class A shares. This setup allows the company to sell shares gradually at current market prices, potentially diluting existing shareholders. SEC

Traders will zero in on key earnings cues: shifts in demand signals, how fast capacity is being added, and whether management plans to tighten or loosen spending for 2026.

There’s a clear risk here. If customer ramp-ups delay, power and equipment bottlenecks hit, or spending outpaces cash coming in, investors might shift their focus from revenue growth to dilution risk and ongoing losses.

Feb. 12 is the next key date — with results out before the bell and a call an hour later. Investors will push for clear updates on deployment timelines, capex, and funding strategies for the coming year.

Stock Market Today

  • Analysts Predict OneSource Specialty Pharma to Breakeven by 2027
    May 21, 2026, 3:29 AM EDT. OneSource Specialty Pharma Limited, a biopharmaceutical firm listed on NSE, currently valued at ₹214 billion, reported a ₹738 million loss in its latest financial year ending March 2026. Industry analysts project the company will continue to post a small loss in 2026 but achieve profitability with ₹4.1 billion earnings by 2027. This forecast implies an ambitious average annual growth rate of 104%, raising questions about execution risks. The company's modest debt level, comprising 22% of equity, suggests prudent capital management and reduced financial risk. With growth expectations high, OneSource's path to breakeven within a year or less depends on successful expansion and product development milestones in the biopharma sector.

Latest articles

Treasury yields close in on 2007 highs, Wall Street takes note

Treasury yields close in on 2007 highs, Wall Street takes note

21 May 2026
The 30-year U.S. Treasury yield reached 5.128% early Thursday, near its highest level since 2007, with the 10-year at 4.593%. Treasury data showed the 30-year par yield at 5.11% Wednesday, down from 5.18% Tuesday. The average 30-year fixed U.S. mortgage rate rose to 6.56%, the highest in seven weeks, as mortgage applications fell 2.3%. Fed minutes showed most policymakers see more tightening if inflation stays above 2%.
Asia Chips Rally Lifts Nvidia, Samsung Shares

Asia Chips Rally Lifts Nvidia, Samsung Shares

21 May 2026
Asian stocks jumped Thursday, led by chipmakers after Nvidia forecast stronger revenue and Samsung Electronics reached a deal to avert a strike. MSCI’s Asia-Pacific index outside Japan rose 2.6%, with South Korea’s KOSPI up over 7% and Samsung shares nearly 8% higher. SK Hynix surged 11.3%. Japan’s exports climbed 14.8% in April, but its services PMI fell to 50.0, ending more than a year of growth.
Sensex edges higher as oil slips, rupee firms

Sensex edges higher as oil slips, rupee firms

21 May 2026
Indian shares trimmed early gains but stayed higher late Thursday morning, with the Nifty 50 up 0.30% and Sensex up 0.20% as oil prices fell and the rupee rebounded. Apollo Hospitals climbed on a 36% profit jump, while Lenskart and Grasim Industries rose after strong earnings. The rupee strengthened after RBI intervention. Ola Electric fell as brokerages stayed cautious.
NIQ Global Intelligence stock sinks after COO exit filing — what investors watch next
Previous Story

NIQ Global Intelligence stock sinks after COO exit filing — what investors watch next

Palantir stock price whipsaws after earnings: PLTR forecast lifts 2026 outlook, then cools
Next Story

Palantir stock price whipsaws after earnings: PLTR forecast lifts 2026 outlook, then cools

Go toTop